We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00525330
First Posted: September 5, 2007
Last Update Posted: August 22, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Kyorin Pharmaceutical Co.,Ltd
Information provided by (Responsible Party):
ActivX Biosciences, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: June 7, 2011